dimethyldioctadecylammonium has been researched along with Tuberculosis, Pulmonary in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banga Ndzouboukou, JL; Fan, X; Hao, L; Lei, Q; Lin, X; Ullah, N; Wu, Y; Zhang, Y; Zhou, Z | 1 |
| Andersen, P; Christensen, D; Pedersen, GK | 1 |
| Giri, PK; Khuller, GK; Verma, I | 1 |
| Brenner, MB; Dascher, CC; Hiromatsu, K; LeClair, KP; Liu, G; McMurray, DN; Morehouse, C; Porcelli, SA; Watts, G; Xiong, X | 1 |
| Giri, PK; Khuller, GK; Sable, SB; Verma, I | 1 |
1 review(s) available for dimethyldioctadecylammonium and Tuberculosis, Pulmonary
| Article | Year |
|---|---|
Immunocorrelates of CAF family adjuvants.
Topics: Adjuvants, Immunologic; Animals; Glycolipids; Humans; Immunity, Cellular; Immunity, Humoral; Immunogenicity, Vaccine; Lipid A; Liposomes; Mice; Quaternary Ammonium Compounds; Th1 Cells; Th17 Cells; Th2 Cells; Tuberculosis Vaccines; Tuberculosis, Pulmonary | 2018 |
4 other study(ies) available for dimethyldioctadecylammonium and Tuberculosis, Pulmonary
| Article | Year |
|---|---|
Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine.
Topics: Adjuvants, Immunologic; Animals; CD4-Positive T-Lymphocytes; Cytokines; Disease Models, Animal; Drug Compounding; Female; Glycolipids; Host-Pathogen Interactions; Immunogenicity, Vaccine; Lipid A; Liposomes; Lung; Mice, Inbred C57BL; Mycobacterium tuberculosis; Quaternary Ammonium Compounds; Receptors, Pattern Recognition; Time Factors; Tuberculosis Vaccines; Tuberculosis, Pulmonary; Vaccination; Vaccines, Subunit; Virulence | 2020 |
Adjunct immunotherapy with Ag85 complex proteins based subunit vaccine in a murine model of Mycobacterium tuberculosis infection.
Topics: Acyltransferases; Adjuvants, Immunologic; Animals; Antigens, Bacterial; Bacterial Load; Bacterial Proteins; Bacterial Vaccines; Cells, Cultured; Humans; Immunotherapy; Interleukin-4; Lung; Mice; Mice, Inbred BALB C; Models, Animal; Mycobacterium tuberculosis; Oligodeoxyribonucleotides; Quaternary Ammonium Compounds; Spleen; T-Lymphocytes; Tuberculosis, Pulmonary | 2009 |
Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis.
Topics: Adjuvants, Immunologic; Administration, Inhalation; Animals; Antigens, CD1; Disease Models, Animal; Female; Glycolipids; Granuloma; Guinea Pigs; Histocytochemistry; Lipids; Liposomes; Lung; Mycobacterium bovis; Mycobacterium tuberculosis; Quaternary Ammonium Compounds; Saponins; Spleen; Tuberculosis, Pulmonary; Vaccines | 2003 |
Comparative evaluation of intranasal and subcutaneous route of immunization for development of mucosal vaccine against experimental tuberculosis.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Bacterial; Bacterial Proteins; Cytokines; Disease Models, Animal; Immunity, Mucosal; Immunoglobulin A; Injections, Subcutaneous; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Quaternary Ammonium Compounds; Tuberculosis Vaccines; Tuberculosis, Pulmonary; Vaccination | 2005 |